SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Scope & Guideline

Exploring New Horizons in Rheumatology Science

Introduction

Explore the comprehensive scope of SCANDINAVIAN JOURNAL OF RHEUMATOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore SCANDINAVIAN JOURNAL OF RHEUMATOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0300-9742
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1959 to 1962, 1964, from 1972 to 2024
AbbreviationSCAND J RHEUMATOL / Scand. J. Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The Scandinavian Journal of Rheumatology focuses on advancing the knowledge and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aims and scopes encompass a wide range of topics related to rheumatology, emphasizing the need for evidence-based practices and innovative treatment approaches.
  1. Rheumatic Disease Mechanisms:
    The journal extensively covers the underlying mechanisms of various rheumatic diseases, including autoimmune responses, genetic predispositions, and inflammatory pathways.
  2. Clinical Trials and Treatment Efficacy:
    A significant focus is placed on clinical trials evaluating the efficacy and safety of new and existing treatments for rheumatic diseases, including biologics and novel therapeutic agents.
  3. Patient-Centered Research:
    Research that highlights patient-reported outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases is a core area of interest, promoting a holistic approach to treatment.
  4. Innovative Diagnostic Techniques:
    The journal publishes studies on new diagnostic methods, including imaging techniques and biomarkers, aimed at improving the diagnosis and monitoring of rheumatic conditions.
  5. Epidemiological Studies:
    Epidemiological research assessing the prevalence, incidence, and risk factors associated with rheumatic diseases is prominently featured, contributing to a better understanding of these conditions.
  6. Interdisciplinary Approaches:
    The journal encourages interdisciplinary research that integrates perspectives from various fields, including immunology, genetics, and rehabilitation sciences, to enhance the understanding and management of rheumatological disorders.
The Scandinavian Journal of Rheumatology has seen a notable shift towards emerging themes that reflect current trends in rheumatology research. These themes not only enhance the understanding of rheumatic diseases but also align with advancements in medical science and patient care.
  1. Digital Health and Telemedicine:
    There is a growing emphasis on digital health interventions and telemedicine, particularly in the context of managing chronic rheumatic diseases during and post-COVID-19, showcasing the adaptation of healthcare practices.
  2. Personalized Medicine and Biomarkers:
    Research focusing on personalized medicine, including the identification of biomarkers for treatment responses and disease progression, is increasingly highlighted, reflecting a trend towards tailored therapies.
  3. Comorbidities and Multidisciplinary Care:
    Studies examining the impact of comorbidities on rheumatic diseases and the importance of multidisciplinary care approaches are gaining traction, emphasizing the need for comprehensive patient management.
  4. Longitudinal and Real-World Data Studies:
    There is a trend towards the use of longitudinal studies and real-world data analyses to assess treatment outcomes and disease progression in diverse populations, providing valuable insights into long-term management.
  5. Psychosocial Aspects of Rheumatic Diseases:
    Research exploring the psychological and social factors affecting patients with rheumatic diseases is emerging, indicating a shift towards understanding the holistic impact of these conditions on patients' lives.

Declining or Waning

While the Scandinavian Journal of Rheumatology continues to grow in various research areas, certain themes have seen a decline in prominence over recent years. This may indicate evolving interests within the field or shifts towards more impactful research questions.
  1. Traditional Pharmacotherapy:
    Research focusing solely on traditional pharmacotherapy options, such as NSAIDs and corticosteroids, appears to be waning as newer biologic and targeted therapies gain prominence.
  2. Case Reports and Isolated Incidents:
    The publication of individual case reports has decreased, possibly due to a shift towards larger cohort studies and clinical trials that provide more generalized data and insights.
  3. Basic Science and Laboratory Studies:
    There seems to be a decline in purely laboratory-based studies that do not directly translate into clinical practice, as the journal emphasizes translational research that bridges the gap between laboratory findings and patient care.

Similar Journals

Rheumatology Advances in Practice

Unlocking the future of rheumatology, one article at a time.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Reumatismo

Connecting researchers and practitioners in the world of rheumatology.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Arthritis & Rheumatology

Fostering Insights for a Healthier Tomorrow
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

RHEUMATOLOGY INTERNATIONAL

Connecting global experts in rheumatology and immunology.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Archives of Rheumatology

Innovative insights into the world of rheumatology.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Reumatologia Clinica

Transforming knowledge into practice in rheumatic health.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

CURRENT OPINION IN RHEUMATOLOGY

Navigating the Frontiers of Rheumatic Disease Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

Pediatric Rheumatology

Empowering healthcare with innovative insights in pediatric rheumatology.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

Egyptian Rheumatology and Rehabilitation

Advancing knowledge in rheumatology and rehabilitation.
Publisher: SPRINGERNATUREISSN: 1110-161XFrequency: 1 issue/year

Egyptian Rheumatology and Rehabilitation is a distinguished open-access journal published by SpringerNature, dedicated to the vital field of rheumatology and rehabilitation. With an E-ISSN of 2090-3235 and a commitment to disseminating high-quality research, this journal serves as a platform for researchers, clinicians, and healthcare professionals to share innovative findings and enhance patient care in musculoskeletal disorders and related conditions. Since its transition to open access in 2013, the journal has prioritized accessibility, allowing a wider audience to engage with groundbreaking studies and clinical insights. By fostering a collaborative environment for knowledge exchange, Egyptian Rheumatology and Rehabilitation plays a crucial role in advancing the understanding of rheumatic diseases and improving rehabilitation strategies. The journal's commitment to quality and relevance in the evolving landscape of rheumatology makes it an invaluable resource for those pursuing excellence in research and practice.

SEMINARS IN ARTHRITIS AND RHEUMATISM

Unveiling the latest in arthritis and pain medicine.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0049-0172Frequency: 6 issues/year

SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.